Published: Fri, December 08, 2017
Markets | By Rosalie Gross

Maverick Capital Ltd. Lowers Position in Walgreens Boots Alliance Inc (WBA)

Truepoint Inc. now owns 668,461 shares of the pharmacy operator's stock worth $668,000 after acquiring an additional 659,847 shares in the last quarter. IBM Retirement Fund increased its holdings in shares of Walgreens Boots Alliance by 88.1% during the 2nd quarter. WBA's financial leverage ratio is 1.36, which indicates that the company's asset base is primarily funded by equity capital.

With an estimated value of 25.55 for 2017, Walgreens Boots Alliance, Inc. has a P/E ratio of 18.81.

Several other institutional investors have also sold shares of the company.

In related news, Director John Anthony Lederer acquired 20,000 shares of the company's stock in a transaction dated Thursday, October 26th. Compared to the average company in the 22.21 space, RAD is relatively cheap. It represents the percentage of a stock's tradable shares that are being shorted. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Analysts have a mean recommendation of 2.20 on this stock. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now directly owns 21,887 shares in the company, valued at approximately $1,879,874.43. The disclosure for this sale can be found here. Insiders own 14.80% of the company's stock.

At the time of writing, the 14-day ADX for Walgreens Boots Alliance (WBA) is 23.85. Walgreens Boots Alliance Inc has a 12-month low of $76.26 and a 12-month high of $89.69. WBA began its day with a share price of $71.05.

More news: House approves bill allowing hide and carry across state lines

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.36 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $1.36. Upon completion, Walgreens Boots Alliance said it would account for this stake as an equity method investment. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance's revenue for the quarter was up 5.3% on a year-over-year basis. analysts predict that Walgreens Boots Alliance Inc will post 5.55 earnings per share for the current fiscal year. This repurchase authorization allows the pharmacy operator to buy shares of its stock through open market purchases.

Analysts look for public financial statements, listen in on conference calls and talk to managers and customers of a company in order to reach an opinion and communicate the value of a stock. Shareholders of record on Thursday, May 18th will be paid a $0.375 dividend. The company was initiated on Friday, November 3 by Credit Suisse. The firm has dividend yield of 1.71% that is also considered as effective indicator. Walgreens Boots Alliance's dividend payout ratio is now 42.33%.

A number of research analysts have recently weighed in on WBA shares. Walgreens Boots Alliance had 46 analyst reports since August 24, 2015 according to SRatingsIntel. The rating was maintained by Loop Capital with "Buy" on Thursday, October 26. The firm earned "Buy" rating on Friday, April 7 by Panmure Gordon. Needham & Company LLC reaffirmed a "buy" rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, October 12th. Studying the numbers can help the investor see whether or not the stock's prospects look good in the near term as well as the longer term.

Walgreens Boots Alliance, Inc. was covered by a number of analysts recently, 7 rated the stock as Buy, 10 rated Hold, 0 rated sell and 0 gave an Underperform. The company now has a consensus rating of Buy and an average target price of $86.47. SunTrust maintained Walgreens Boots Alliance, Inc. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & global trademark and copyright laws. Parasol Investment Management LLC increased its position in Walgreens Boots Alliance by 3.5% in the third quarter.

The agreement, between Sinopharm subsidiary China National Accord Medicines and Walgreens Boots Alliance, the largest retail pharmacy and health care chain across the United States and Europe, will see the latter purchase a 40 per cent stake in Sinopharm Holding Guoda Drugstores, as it seeks to take advantage of the growing interest in health care among Asian consumers, according to Sinopharm.

Like this: